Staar Surgical rises after Stifel upgrades to buy and lifts price target
Stifel upgraded Staar Surgical to buy from hold, citing EVO+ lens adoption in China and improving international demand. The brokerage raised its PT to $31 from $28.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Staar Surgical Raised to Buy From Hold by Stifel
Ratings actions from Benzinga